LRMR – larimar therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $25.00 price target on the stock.
Larimar Therapeutics Selected by FDA to Participate in START Pilot Program for Nomlabofusp in Friedreich's Ataxia [Yahoo! Finance]
Larimar Therapeutics Selected by FDA to Participate in START Pilot Program for Nomlabofusp in Friedreich’s Ataxia
Larimar Therapeutics, Inc. (NASDAQ: LRMR) had its price target raised by analysts at Citigroup Inc. from $10.00 to $14.00. They now have a "buy" rating on the stock.
Larimar (LRMR) Up on Lifting of Partial Clinical Hold on FA Study [Yahoo! Finance]
Form 8-K Larimar Therapeutics, For: Jun 10
Form 4 Larimar Therapeutics, For: May 29 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
Form 4 Larimar Therapeutics, For: May 29 Filed by: LEFF JONATHAN S
Form 4 Larimar Therapeutics, For: May 29 Filed by: THOMAS FRANK E
Form 4 Larimar Therapeutics, For: May 29 Filed by: SHERMAN JEFFREY W
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.